Journal
VIRUS RESEARCH
Volume 301, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.virusres.2021.198454
Keywords
SARS-CoV-2; Coronavirus; Vaccine strategies; Vaccine safety; Emergency use
Categories
Funding
- Bahia State Research Support Foundation
Ask authors/readers for more resources
The COVID-19 pandemic has caused significant social and economic disruptions, prompting a global effort to develop effective vaccines. Designing and developing vaccines involves multiple stages, including selecting appropriate platforms, conducting clinical trials, and scaling up production. The world is facing various challenges in combating the pandemic, requiring collaborative efforts to overcome them.
COVID-19 pandemic has resulted in millions of deaths and a social-economic crisis. A worldwide effort was made to develop efficient vaccines for this disease. A vaccine should produce immune responses with specific and neutralizing antibodies, and without harmful effects such as the antibody-dependent enhancement that may be associated with severe acute respiratory syndrome. Vaccine design involves the selection of platforms that includes viral, viral-vector, protein, nucleic acid, or trained immunity-based strategies. Its development initiates at a pre-clinical stage, followed by clinical trials when successful. Only if clinical trials show no significant evidence of safety concerns, vaccines can be manufactured, stored, and distributed to immunize the population. So far, regulatory authorities from many countries have approved nine vaccines with phase 3 results. In the current pandemic, a paradigm for the COVID-19 vaccine development has arisen, as many challenges must be overcome. Mass-production and cold-chain storage to immunize large human populations should be feasible and fast, and a combination of different vaccines may boost logistics and immunization. In silico trials is an emerging and innovative field that can be applied to predict and simulate immune, molecular, clinical, and epidemiological outcomes of vaccines to refine, reduce, and partially replace steps in vaccine development. Vaccine-resistant variants of SARS-CoV-2 might emerge, leading to the necessity of updates. A globally fair vaccine distribution system must prevail over vaccine nationalism for the world to return to its pre-pandemic status.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available